Cost-effectiveness of bariatric surgery for severely obese adults with diabetes

Diabetes Care

Volumn 33, Issue 9, 2010, Pages 1933-1939

  Hoerger, Thomas J ^a   Zhang, Ping ^b   Segel, Joel E ^c   Kahn, Henry S ^b   Barker, Lawrence E ^b   Couper, Steven ^a  

^a RTI INTERNATIONAL   (United States)

^b NATIONAL CENTER FOR CHRONIC DISEASE PREVENTION AND HEALTH PROMOTION   (United States)

^c UNIVERSITY OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BARIATRIC SURGERY; BODY MASS; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DIABETIC NEPHROPATHY; DIABETIC NEUROPATHY; DIABETIC RETINOPATHY; DISEASE SEVERITY; FEMALE; GLYCEMIC CONTROL; HEALTH CARE COST; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PATIENT CARE; PERIOPERATIVE PERIOD; PUBLIC HEALTH SERVICE; QUALITY ADJUSTED LIFE YEAR; QUALITY OF LIFE; RECURRENT DISEASE; REMISSION; RISK FACTOR; SENSITIVITY ANALYSIS; STOMACH BYPASS; STROKE; SURGICAL MORTALITY;

ADULT; AGED; AGED, 80 AND OVER; BARIATRIC SURGERY; COST-BENEFIT ANALYSIS; DIABETES MELLITUS; FEMALE; HUMANS; MALE; MIDDLE AGED; OBESITY; QUALITY-ADJUSTED LIFE YEARS;

EID: 78651361894     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc10-0554     Document Type: Article

References (25)

1. Buchwald H, Estok R, Fahrbach K, Banel D, Jensen MD, Pories WJ, Bantle JP, Sledge I. Weight and type 2 diabetes after bariatric surgery: systematic review and meta-analysis. Am J Med 2009;122:248-256
2. Maggard MA, Shugarman LR, Suttorp M, Maglione M, Sugarman HJ, Livingston EH, Nguyen NT, Li Z, Mojica WA, Hilton L, Rhodes S, Morton SC, Shekelle PG. Meta-analysis: surgical treatment of obesity. Ann Intern Med 2005;142:547-559
3. Sjostrom L, Lindroos AK, Peltonen M, Torgerson J, Bouchard C, Carlsson B, Dahlgren S, Larsson B, Narbro K, Sjostrom CD, Sullivan M, Wedel H. Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery. N Engl J Med 2004;351:2683-2693 (Pubitemid 39665322)
4. Sjostrom L, Narbro K, Sjostrom D, Karason K, Larsson B, Wedel H, Lystig T, Sullivan M, Bouchard C, Carlsson B, Bengtsson C, Dahlgren S, Gummesson A, Jacobson P, Karlsson J, Lindross AK, Lonroth H, Naslund I, Olbers T, Stenlof K, Torgerson J, Agren G, Carlsson LMS. Effects of bariatric surgery on mortality in Swedish obese subjects. N Engl J Med 2007;357:741-752 (Pubitemid 47295641)
5. Encinosa WE, Bernard DM, Steiner CA, Chen CC. Use and costs of bariatric surgery and prescription weight-loss medications. Health Affairs 2005;24:1039-1046 (Pubitemid 41058604)
6. Cremieux PY, Buchwald H, Shikora SA, Ghosh A, Yang HE, Buessing M. A study on the economic impact of bariatric surgery. Am J Manag Care 2008;14:589-596
7. Clegg A, Colquitt J, Sidhu M, Royle P, Walker A. Clinical and cost effectiveness of surgery for morbid obesity: a systematic review and economic evaluation. Int J Obes Relat Metab Disord 2003;27:1167-1177 (Pubitemid 37281664)
8. Craig BM, Tseng DS. Cost-effectiveness of gastric bypass for severe obesity. Am J Med 2002;113:491-498 (Pubitemid 35335802)
9. Salem L, Devlin A, Sullivan SD, Flum DR. Cost-effectiveness analysis of laparoscopic gastric bypass, adjustable gastric banding, and nonoperative weight loss interventions. Surg Obes Relat Dis 2008;4: 26-32
10. Ikramuddin S, Klingman D, Swan T, Minshall ME. Cost-effectiveness of Roux-en-Y gastric bypass in type 2 diabetes patients. Am J Manag Care 2009;15:607-615
11. Ackroyd R, Mouiel J, Chevallier JM, Daoud F. Cost-effectiveness and budget impact of obesity surgery in patients with type-2 diabetes in three European countries. Obes Surg 2006;16:1488-1503 (Pubitemid 44759983)
12. Finkelstein EA, Brown DS. A cost-benefit simulation model of coverage for bariatric surgery among full-time employees. Am J Manag Care 2005;11:641-646 (Pubitemid 41527684)
13. Keating CL, Dixon JB, Moodie ML, Peeters A, Bulfone L, Maglianno DJ, O'Brien PE. Cost-effectiveness of surgically induced weight loss for the management of type 2 diabetes: modeled lifetime analysis. Diabetes Care 2009;32:567-574
14. CDC Diabetes Cost-Effectiveness Group (Corresponding Author: T.J. Hoerger). Cost-effectiveness of intensive glycemic control, intensified hypertension control, and serum cholesterol level reduction for type 2 diabetes. JAMA 2002;287:2542-2551
15. Herman WH, Hoerger TJ, Brandle M, Hicks K, Sorensen S, Zhang P, Hamman RF, Ackermann RT, Engelgau MM, Ratner RE. Diabetes Prevention Program Research Group. The cost-effectiveness of lifestyle modification or metformin in preventing type 2 diabetes in adults with impaired glucose tolerance. Ann Intern Med 2005;142:323-332
16. Hoerger TJ, Segel JE, Zhang P, Sorensen SW. Validation of the CDC-RTI Diabetes Cost-Effectiveness Model. RTI Press Methods Report, Research Triangle Part, NC, RTI International, 2009
17. Brancatisano A, Wahlroos S, Matthews S, Brancatisano R. Gastric banding for the treatment of type 2 diabetes mellitus in morbidly obese. Surg Obes Relat Dis 2008;4:423-429
18. Schauer PR, Burguera B, Ikramuddin S, Cottam D, Gourash W, Hamad G, Eid GM, Mattar S, Ramanathan R, Barinas- Mitchel E, Rao RH, Kuller L, Kelley D. Effect of laparoscopic Roux-en-Y gastric bypass on type 2 diabetes mellitus. Ann Surg 2003;238:467-485 (Pubitemid 38176385)
19. Buchwald H, Estok R, Fahrbach K, Banel D, Sledge I. Trends in mortality in bariatric surgery: a systematic review and metaanalysis. Surgery 2007;142:621-635 (Pubitemid 47575601)
20. UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes. Lancet 1998;352:837-853
21. U.S. Department of Labor, Bureau of Labor Statistics. Consumer Price Index, [article online]. Available from http://data.bls.gov/cgi-bin/surveymost? cu. Accessed 15 April 2009
22. Angrisani L, Di Lorenzo N, Favretti F, Furbetta F, Iuppa A, Doldi SB, Paganelli M, Basso N, Lucchese M, Zappa M, Lesti G, Capizzi FD, Giardiello C, Paganini A, Di Cosmo L, Veneziani A, Lacitignola S, Silecchia G, Alkilani M, Forestieri P, Puglisi F, Gardinazzi A, Toppino M, Campanile F, Marzano B, Bernante P, Perrotta G, Borrelli V, Lorenzo M, the Italian Collaborative Study Group for LAP-BAND. Predictive value of initial body mass index for weight loss after 5 years of follow-up Surg Endosc 2004;18:1524-1527
23. Grosse SD. Assessing cost-effectiveness in healthcare: history of the $50,000 per QALY threshold. Expert Rev Pharmacoeconomics Outcomes Res 2008;8:165-178 (Pubitemid 351959547)
24. National Institutes of Health (NIH). Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults: The Evidence Report. Bethesda, MD, NIH, 1998 [NIH publication no. 98-4083]
25. Dixon JB, O'Brien PE, Playfair J, Chapman L, Schachter LM, Skinner S, Proietto J, Bailey M, Anderson M. Adjustable gastric banding and conventional therapy for type 2 diabetes: a randomized controlled trial. JAMA 2008;299(3):316-323 (Pubitemid 351159368)